Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel R Rhodes

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Science (New York, N.Y.)|October 29, 2005
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancerScott A Tomlins, Daniel R Rhodes, Sven Perner, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 3, 2009
AGTR1 overexpression defines a subset of breast cancer and confers sensitivity to losartan, an AGTR1 antagonistDaniel R Rhodes, Bushra Ateeq, Qi Cao, et al.
Cancer Research|June 3, 2004
Overexpression, amplification, and androgen regulation of TPD52 in prostate cancerMark A Rubin, Sooryanarayana Varambally, Rameen Beroukhim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
Delineation, functional validation, and bioinformatic evaluation of gene expression in thyroid follicular carcinomas with the PAX8-PPARG translocationThomas J Giordano, Amy Y M Au, Rork Kuick, et al.
Molecular Cancer Research : MCR|January 17, 2015
Next-Gen Sequencing Exposes Frequent MED12 Mutations and Actionable Therapeutic Targets in Phyllodes TumorsAndi K Cani, Daniel H Hovelson, Andrew S McDaniel, et al.
Cancer Research|December 21, 2017
The CARMA3-Bcl10-MALT1 Signalosome Drives NFκB Activation and Promotes Aggressiveness in Angiotensin II Receptor-Positive Breast CancerPrasanna Ekambaram, Jia-Ying Lloyd Lee, Nathaniel E Hubel, et al.
Cancer Research|December 17, 2015
Genomic Profiling of Penile Squamous Cell Carcinoma Reveals New Opportunities for Targeted TherapyAndrew S McDaniel, Daniel H Hovelson, Andi K Cani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2021
Virus-positive Merkel Cell Carcinoma Is an Independent Prognostic Group with Distinct Predictive BiomarkersKelly L Harms, Lili Zhao, Bryan Johnson, et al.
Cancer Discovery|April 6, 2013
Identification of targetable FGFR gene fusions in diverse cancersYi-Mi Wu, Fengyun Su, Shanker Kalyana-Sundaram, et al.
Nature|June 23, 2012
The mutational landscape of lethal castration-resistant prostate cancerCatherine S Grasso, Yi-Mi Wu, Dan R Robinson, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Science (New York, N.Y.)|October 29, 2005
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancerScott A Tomlins, Daniel R Rhodes, Sven Perner, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 3, 2009
AGTR1 overexpression defines a subset of breast cancer and confers sensitivity to losartan, an AGTR1 antagonistDaniel R Rhodes, Bushra Ateeq, Qi Cao, et al.
Cancer Research|June 3, 2004
Overexpression, amplification, and androgen regulation of TPD52 in prostate cancerMark A Rubin, Sooryanarayana Varambally, Rameen Beroukhim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
Delineation, functional validation, and bioinformatic evaluation of gene expression in thyroid follicular carcinomas with the PAX8-PPARG translocationThomas J Giordano, Amy Y M Au, Rork Kuick, et al.
Molecular Cancer Research : MCR|January 17, 2015
Next-Gen Sequencing Exposes Frequent MED12 Mutations and Actionable Therapeutic Targets in Phyllodes TumorsAndi K Cani, Daniel H Hovelson, Andrew S McDaniel, et al.
Cancer Research|December 21, 2017
The CARMA3-Bcl10-MALT1 Signalosome Drives NFκB Activation and Promotes Aggressiveness in Angiotensin II Receptor-Positive Breast CancerPrasanna Ekambaram, Jia-Ying Lloyd Lee, Nathaniel E Hubel, et al.
Cancer Research|December 17, 2015
Genomic Profiling of Penile Squamous Cell Carcinoma Reveals New Opportunities for Targeted TherapyAndrew S McDaniel, Daniel H Hovelson, Andi K Cani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2021
Virus-positive Merkel Cell Carcinoma Is an Independent Prognostic Group with Distinct Predictive BiomarkersKelly L Harms, Lili Zhao, Bryan Johnson, et al.
Cancer Discovery|April 6, 2013
Identification of targetable FGFR gene fusions in diverse cancersYi-Mi Wu, Fengyun Su, Shanker Kalyana-Sundaram, et al.
Nature|June 23, 2012
The mutational landscape of lethal castration-resistant prostate cancerCatherine S Grasso, Yi-Mi Wu, Dan R Robinson, et al.
Pageof 5